Oncology Institute (TOI) Institutional Ownership $2.46 +0.03 (+1.02%) Closing price 07/3/2025 03:55 PM EasternExtended Trading$2.47 +0.01 (+0.20%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oncology Institute (NASDAQ:TOI)CurrentInstitutional OwnershipPercentage36.86%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$3.58MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$978.67K Get TOI Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncology Institute stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TOI Institutional Buying and Selling by Quarter Oncology Institute Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.115,140$131K0.0%N/A0.129% 5/16/2025Goldman Sachs Group Inc.115,140$131K0.0%N/A0.152% 5/16/2025Josh Arnold Investment Consultant LLC1,988,900$2.27M1.9%N/A2.632% 5/9/2025Citizens Financial Group Inc. RI62,700$71K0.0%N/A0.083% 5/9/2025WealthShield Partners LLC70,154$80K0.0%N/A0.093% 5/8/2025Cincinnati Insurance Co.1,240,795$1.42M0.0%-39.0%1.642% 5/8/2025XTX Topco Ltd55,698$63K0.0%+49.5%0.074% 5/6/2025FreeGulliver LLC544,361$621K0.3%-9.4%0.720% 2/14/2025Jane Street Group LLC127,659$39K0.0%+613.6%0.169% 2/13/2025Renaissance Technologies LLC182,000$56K0.0%+7.1%0.241% Get the Latest News and Ratings for TOI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025Geode Capital Management LLC347,347$107K0.0%-8.6%0.460% 2/11/2025Virtu Financial LLC131,759$41K0.0%N/A0.174% 2/11/2025FreeGulliver LLC600,747$186K0.1%+219.3%0.795% 2/6/2025Tiff Advisory Services LLC2,979,141$921K0.3%+13.2%3.943% 11/15/2024HighTower Advisors LLC81,362$27K0.0%+190.8%0.108% 8/9/2024Renaissance Technologies LLC339,400$156K0.0%+142.3%0.456% 8/7/2024Tiff Advisory Services LLC1,418,685$653K0.2%+235.1%1.906% 5/16/2024FourWorld Capital Management LLC250,359$396K0.3%N/A0.337% 5/16/2024Kent Lake Capital LLC1,186,713$1.88M0.8%+9.4%1.597% 5/14/2024Element Pointe Advisors LLC199,026$314K0.1%-50.0%0.268% 5/10/2024Nwam LLC27,679$44K0.0%N/A0.037% 4/18/2024Quattro Financial Advisors LLC55,960$88K0.0%N/A0.075% 2/14/2024Kent Lake Capital LLC1,085,171$2.21M0.9%+492.3%1.471% 2/13/2024Tower Research Capital LLC TRC 12,046$25K0.0%N/A0.016% 2/8/2024Cincinnati Insurance Co.699,500$1.43M0.0%N/A0.948% 2/7/2024Josh Arnold Investment Consultant LLC1,856,329$3.79M3.7%-1.1%2.517% 2/6/2024Fielder Capital Group LLC70,192$143K0.1%N/A0.095% 1/23/2024WealthShield Partners LLC24,126$49K0.0%N/A0.033% 1/1/2024Vanguard Group Inc.1,758,034$2.46M0.0%-0.3%2.384% 11/22/2023Josh Arnold Investment Consultant LLC1,877,472$2.65M2.8%+77.4%2.546% 11/15/2023Kent Lake Capital LLC183,215$257K0.1%N/A0.251% 11/14/2023Saba Capital Management L.P.94,264$132K0.0%-44.7%0.129% 11/8/2023Vanguard Personalized Indexing Management LLC21,269$30K0.0%N/A0.029% 11/8/2023Tiff Advisory Services LLC423,405$593K0.5%N/A0.580% 9/7/2023Triatomic Management LP904,689$498K0.5%+11.7%1.240% 8/14/2023Prosight Management LP455,302$251K0.1%+61.5%0.604% 5/3/2023Triatomic Management LP810,145$549K0.4%+56.6%1.087% 2/16/2023Josh Arnold Investment Consultant LLC104,400$172K0.3%N/A0.140% 2/14/2023Triatomic Management LP517,479$854K0.7%+41.5%0.695% 11/16/2022Saba Capital Management L.P.348,059$1.61M0.0%-5.2%0.475% Elon’s Revenge (Ad)Elon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is this: Before he left Washington, Elon Musk left a "parting gift" to folks, which could help you double your money multiple times this year. Everything you need to know is right here.By July 22 – at the absolute latest – Elon's Final Gift could see trillions of dollars change hands.11/15/2022Parian Global Management LP240,724$1.12M3.6%+31.0%0.329% 11/8/2022New York State Common Retirement Fund10,974$51K0.0%-30.5%0.015% 10/26/2022Allspring Global Investments Holdings LLC10,919$50K0.0%N/A0.015% 8/16/2022Parian Global Management LP183,828$930K4.3%-58.6%0.251% 8/16/2022Deerfield Management Company L.P. Series C3,383,099$17.12M0.4%+2.6%4.617% 5/17/2022Empery Asset Management LP70,733$504K2.4%-64.6%0.097% 5/12/2022Triatomic Management LP428,100$3.05M2.5%+7.0%0.584% 5/9/2022Qube Research & Technologies Ltd37,850$270K0.0%+102.5%0.052% 2/15/2022Saba Capital Management L.P.400,000$3.73M0.1%N/A1.391% 2/14/2022Parian Global Management LP466,676$4.55M3.7%N/A1.623% 2/14/2022Redmile Group LLC2,500,000$24.38M0.6%N/A8.696% 2/14/2022Deerfield Management Company L.P. Series C3,296,107$32.14M0.7%N/A11.465% 2/10/2022Qube Research & Technologies Ltd18,688$182K0.0%N/A0.065% (Data available from 1/1/2016 forward) TOI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TOI shares? During the previous two years, 25 institutional investors and hedge funds held shares of Oncology Institute. The most heavily invested institutionals were Vanguard Group Inc. ($2.46M), Josh Arnold Investment Consultant LLC ($2.27M), Kent Lake Capital LLC ($1.88M), Cincinnati Insurance Co. ($1.42M), Tiff Advisory Services LLC ($921K), FreeGulliver LLC ($621K), and Triatomic Management LP ($498K).Learn more on Oncology Institute's institutional investors. What percentage of Oncology Institute's stock is owned by institutional investors? 36.86% of Oncology Institute's stock is owned by institutional investors. Learn more on TOI's institutional investor holdings. Which institutional investors have been buying Oncology Institute's stock? Of the 21 institutional investors that purchased Oncology Institute's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Josh Arnold Investment Consultant LLC ($2.81M), Tiff Advisory Services LLC ($1.76M), Kent Lake Capital LLC ($1.19M), Cincinnati Insurance Co. ($699.50K), FreeGulliver LLC ($412.58K), FourWorld Capital Management LLC ($250.36K), and Goldman Sachs Group Inc. ($230.28K). How much institutional buying is happening at Oncology Institute? Institutional investors have bought a total of 4,630,806 shares in the last 24 months. This purchase volume represents approximately $3.58M in transactions. Which of Oncology Institute's major shareholders have been selling company stock? The following institutional investors have sold Oncology Institute stock in the last 24 months: Cincinnati Insurance Co. ($793.25K), FreeGulliver LLC ($56.39K), and Geode Capital Management LLC ($32.63K). How much institutional selling is happening at Oncology Institute? Institutional investors have sold a total of 882,270 shares in the last 24 months. This volume of shares sold represents approximately $978.67K in transactions. Related Companies LifeMD Major Shareholders Fulgent Genetics Major Shareholders Castle Biosciences Major Shareholders Personalis Major Shareholders InnovAge Major Shareholders Enhabit Major Shareholders Celcuity Major Shareholders Auna Major Shareholders Talkspace Major Shareholders Fortrea Major Shareholders This page (NASDAQ:TOI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
